Innovation is one of our fundamental strategic pillars
The OEM Technology Center innovates at all levels: biomaterials, assays and manufacturing biotechnology processes.
Open innovation is not a new concept for us; since the 1980s, we have been collaborating with prestigious universities, research centers and companies around the world to constantly offer the most advanced solutions.
Assay innovation includes design of prototypes and proof-of-concept evaluation to verify biomaterials and reagent formulation for new immunoassays.
Innovation in biotechnology
Innovation in biotechnology includes biotechnology products and processes for enhanced assay performance (sensitivity, specificity, stability) and for enhanced assay manufacturing processes (high yield, high scalability and robust production of antigens and antibodies).